MedTrace Logo

Tracking Depression Symptoms With a Health Chatbot

NCT03990389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-05-12

Study results available
· View outcomes & findings →

Summary

The goal of this research is to bridge a significant "effectiveness" gap in the treatment of depression. The investigators have developed a chatbot which will assist in performing measurement-based care (MBC) via Facebook Messenger. Participants will be randomized to either Usual Care or Usual Care with additional Chatbot Care.

Conditions

  • Depression, Postpartum
  • Depression, Unipolar

Interventions

DEVICE

Chatbot Intervention

a chatbot will be used to monitor depression severity

Sponsors & Collaborators

  • Endeavor Health

    collaborator OTHER

  • University of Chicago

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2020-02-29
Completion
2020-02-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03990389 on ClinicalTrials.gov